Reproductive History and Risk of Colorectal Cancer in Postmenopausal Women
Open Access
- 29 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 103 (10) , 826-834
Abstract
There are conflicting data regarding the role of sex hormones in colorectal cancer development. Whereas clinical trials data indicate that hormone therapy use reduces the risk of colorectal cancer, data from prospective cohort studies suggest that circulating estrogen levels are positively associated with colorectal cancer risk. A surrogate measure of lifetime estrogen exposure is reproductive history. We investigated the relationship between reproductive factors and the risk of colorectal cancer. Subjects were postmenopausal women enrolled in the National Institutes of Health–American Association of Retired Persons Diet and Health Study, a cohort of 214 162 individuals (aged 50–71 years) that included 2014 incident cases of colorectal cancer that occurred over a mean follow-up of 8.2 years. Questionnaires were used to collect data on reproductive factors, including ages at menarche, birth of first child, and menopause; parity, and use of oral contraceptives. Multivariable Cox proportional hazards models were constructed to examine associations between these reproductive factors and the risk of colorectal cancer, with adjustment for established colorectal cancer risk factors. All statistical tests were two-sided. Age at menopause (≥55 vs Ptrend = .008) and age at birth of first child (≥30 vs ≤19 years: HR = 1.26, 95% CI = 1.01 to 1.58; Ptrend = .05) were positively associated with the risk of colorectal cancer. Among women with no history of hormone therapy use, age at menarche (≥15 vs 11–12 years: HR = 0.73, 95% CI = 0.57 to 0.94; Ptrend = .02) and parity (≥5 children vs no children: HR = 0.80, 95% CI = 0.63 to 1.02; Ptrend = .10) were inversely associated with the risk of colorectal cancer. These data support a role for sex hormones in colorectal tumorigenesis and suggest that greater endogenous estrogen exposure may increase the risk of colorectal cancer in postmenopausal women.Keywords
This publication has 50 references indexed in Scilit:
- Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and NutritionBritish Journal of Cancer, 2010
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesThe Lancet Oncology, 2010
- Lactation and Incidence of Premenopausal Breast CancerArchives of internal medicine (1960), 2009
- Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial CohortBMC Cancer, 2009
- Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic FactorsCancer Research, 2009
- Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2009
- Conjugated Equine Estrogens and Colorectal Cancer Incidence and Survival: The Women's Health Initiative Randomized Clinical TrialCancer Epidemiology, Biomarkers & Prevention, 2008
- Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal WomenCancer Research, 2008
- Design and Serendipity in Establishing a Large Cohort with Wide Dietary Intake DistributionsAmerican Journal of Epidemiology, 2001
- Oral contraceptives and colorectal cancer risk: a meta-analysisBritish Journal of Cancer, 2001